Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Merck
QuintilesIMS
Boehringer Ingelheim
Express Scripts
Covington
Dow
Fish and Richardson
AstraZeneca

Generated: December 16, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TELOTRISTAT ETIPRATE

« Back to Dashboard

Clinical Trials for Telotristat Etiprate

Trial ID Title Status Sponsor Phase Summary
NCT01677910 TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) Completed Lexicon Pharmaceuticals Phase 3 The primary objective of the study is to confirm that at least 1 or more doses of telotristat etiprate compared to placebo is effective in reducing the number of daily bowel movements (BMs) from baseline averaged over the 12-week double-blind portion (Treatment Period) of the trial in patients not adequately controlled by current SSA therapy.
NCT01932528 An Open-label Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]-Telotristat Etiprate in Males Completed Lexicon Pharmaceuticals Phase 1 To evaluate the metabolism and routes and extent of elimination of telotristat etiprate and its primary metabolite LX1033.
NCT02026063 Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms Active, not recruiting Lexicon Pharmaceuticals Phase 3 The primary objective of this study is to evaluate the long-term safety and tolerability of orally administered telotristat etiprate.
NCT02063659 Telotristat Etiprate for Carcinoid Syndrome Therapy Completed Lexicon Pharmaceuticals Phase 3 The purpose of the study is to evaluate the effect of telotristat etiprate versus placebo on the incidence of treatment-emergent adverse events and on 5-hydroxyindoleacetic acid (5-HIAA) levels.
NCT02147808 A Open-Label Drug-Drug Interaction Study of Telotristat Etiprate and Midazolam in Healthy Subjects Completed Lexicon Pharmaceuticals Phase 1 This study is designed to evaluate the effects of telotristat ethyl on the pharmacokinetics of midazolam in healthy male and female subjects.
NCT02155205 A Thorough QT Study of Telotristat Etiprate Completed Lexicon Pharmaceuticals Phase 1 The purpose of this study is to demonstrate that telotristat etiprate does not differ from placebo in the mean change from Baseline QT interval corrected for heart rate.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Telotristat Etiprate

Condition Name

Condition Name for Telotristat Etiprate
Intervention Trials
Carcinoid Syndrome 5
Drug Interactions 3
Renal Impairment 1
QT Interval 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Telotristat Etiprate
Intervention Trials
Serotonin Syndrome 5
Malignant Carcinoid Syndrome 5
Syndrome 3
Carcinoid Tumor 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Telotristat Etiprate

Trials by Country

Trials by Country for Telotristat Etiprate
Location Trials
United States 32
Australia 11
Canada 6
Belgium 4
Germany 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Telotristat Etiprate
Location Trials
Pennsylvania 3
New York 3
Massachusetts 3
Kentucky 3
Iowa 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Telotristat Etiprate

Clinical Trial Phase

Clinical Trial Phase for Telotristat Etiprate
Clinical Trial Phase Trials
Phase 3 3
Phase 2 1
Phase 1 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Telotristat Etiprate
Clinical Trial Phase Trials
Completed 10
Active, not recruiting 1
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Telotristat Etiprate

Sponsor Name

Sponsor Name for Telotristat Etiprate
Sponsor Trials
Lexicon Pharmaceuticals 9
Ipsen 2
Barbara Ann Karmanos Cancer Institute 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Telotristat Etiprate
Sponsor Trials
Industry 11
NIH 1
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Chubb
Express Scripts
Baxter
Cantor Fitzgerald
AstraZeneca
Argus Health
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.